On the HCPLive Ulcerative Colitis condition center page, resources on the topics of medical news and expert insight into colitis can be found. Content includes articles, interviews, videos, podcasts, and breaking news on UC research, treatment, and drug development.
September 11th 2024
The decision is based on rates of clinical and endoscopic remission with guselkumab in the ongoing phase 2b/3 QUASAR study.
Gastric Troubles Traced to Pathogenesis in the Gut
In Europe and the United States, more than 3 million people suffer from either Crohn's disease or ulcerative colitis, and while they are becoming more common diagnoses, the root causes and triggers are not completely clear to researchers.
Can Prebiotics and Probiotics Really Improve Gastrointestinal Health?
June 3rd 2014Prebiotics and probiotics have been discussed frequently in the media for supposedly improving overall health, especially diseases related to the gut. However, the evidence on the efficacy and use of these dietary supplements is rather complicated.
Promising Initial Results from Novel Treatment for Ulcerative Colitis
May 5th 2014Phase 2 study results show patients with ulcerative colitis treated with an investigational oral compound achieved higher rates of remission, reduced rectal bleeding, and increased mucosal healing compared to patients who received placebo.
Opioid-induced Constipation Is More Than a Tolerability Issue
Though constipation as a side effect of opioid therapy is generally considered a tolerability issue that can be treated with over-the-counter laxatives, opioid-induced constipation may still lead to serious gastrointestinal complications.
Isotretinoin and Inflammatory Bowel Disease: Is There a Link?
April 10th 2014Isotretinoin, a treatment for severe acne, has been linked to inflammatory bowel disease (IBD) in some case reports and 1 study. To investigate whether isotretinoin can induce IBD, French researchers conducted a 2-year nationwide registry study.
Weighing the Benefits of Combination Therapy in Crohn's Disease
March 10th 2014Recent studies suggest that combination therapy with infliximab and azathioprine is more effective than monotherapy in patients with newly diagnosed Crohn's disease, but patients with more established Crohn's disease do not derive any extra benefit from triple therapy with infliximab, methotrexate, and prednisone compared to double therapy with infliximab and prednisone.
Effective Management of Fecal Incontinence Requires Thorough Physical Exam, History
January 19th 2014Clinicians should be familiar with all current testing options and assessment tools and be prepared to offer support and guidance to patients who may be embarrassed or unwilling to discuss this aspect of their health.
In the Future, IBD Treatment Will Focus on More Cost-Effective, Quality Care
January 18th 2014With renewed attention on maximizing return on every dollar spent on health care, gastroenterologists need to take a thoughtful approach that takes cost and the overall patient experience into account when they make testing and treatment decisions with patients who have inflammatory bowel disease.
Thalidomide Extends Remission Duration in Children with Crohn's Disease
A new randomized, double-blind, placebo-controlled study of 56 children with Crohn's disease suggests pediatric patients treated with thalidomide have better rates of remission and response than those given placebo.
Preventative Measures for Upper Gastrointestinal Tract Bleeding
Primary prevention measures for upper GI bleeding should include NSAIDs, antiplatelet therapy, and anticoagulants appropriately, while secondary preventive measures should include testing and treating H. pylori and using long-term PPIs when appropriate.
EMR Analysis Reveals Significant Predictors of Fibromyalgia Diagnosis
Noting that it takes an average of 5 years before a fibromyalgia patient receives a diagnosis, researchers conducted a retrospective data analysis to identify significant variables that may enable earlier detection and diagnosis of fibromyalgia.